Cargando…
Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients
The treatment of chronic lymphocytic leukemia (CLL) is in rapid transition, and during recent decades both combination chemotherapy and immunotherapy have been introduced. To evaluate the effects of this development, we identified all CLL patients registered in the nation-wide Danish Cancer Register...
Autores principales: | da Cunha-Bang, C, Simonsen, J, Rostgaard, K, Geisler, C, Hjalgrim, H, Niemann, C U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148052/ https://www.ncbi.nlm.nih.gov/pubmed/27834937 http://dx.doi.org/10.1038/bcj.2016.105 |
Ejemplares similares
-
IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study
por: Rotbain, Emelie Curovic, et al.
Publicado: (2020) -
Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia
por: Rotbain, Emelie C, et al.
Publicado: (2021) -
The Danish National Chronic Lymphocytic Leukemia Registry
por: da Cunha-Bang, Caspar, et al.
Publicado: (2016) -
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Time to Retire?
por: Scarfò, Lydia, et al.
Publicado: (2019) -
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Passé Yet?
por: Danilov, Alexey V., et al.
Publicado: (2019)